Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAINT: PET-Adjusted IMRT and Chemotherapy for NSCLC
NCT02073968Phase 2Completed
- Sponsor
- Albert Einstein College of Medicine
- Start
- Jul 2013
- Primary completion
- Dec 2017
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, Paclitaxel Micelles for Injection in non-small cell lung cancer (NSCLC), sponsored by Albert Einstein College of Medicine. Started Jul 2013; status: completed.
02
Drugs
carboplatinPaclitaxel Micelles for Injection
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02073968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02073968.